Delphinus Medical Technologies | Mark Forchette, CEO
The patented technology is a 3D whole breast ultrasound imaging device that delivers no radiation, requires no compression, and images the entire breast with a single scan.
CytoVeris | Alan Kersey, President & CEO
CytoVeris is harnessing precise, smart cancer imaging solutions, by converging advanced optical imaging technologies and artificial intelligence to bring new, real-time, intraoperative cancer visualization capabilities to the operating room in order to improve the quality of cancer resections, enhance patient outcomes and reduce economic burden across the healthcare continuum.
Onkos Surgical | Patrick Treacy, CEO
Onkos Surgical delivers high quality implants and instruments that meet the unique needs of musculoskeletal tumor patients.
MedTrace Pharma | Martin Stenfeldt, CEO
MedTrace Pharma A/S is a development stage company aiming to innovate PET diagnostic imaging by transforming blood flow quantification.
ChemoTech | Mohan Frick, CEO
The company is dedicated to innovation in cancer care and recently launched IQwave. This technology performs electrochemotherapy which is approved for the treatment of a wide range of tumors.
Siva Therapeutics | Len Pagliaro, CEO
SIVA Therapeutics mission is to develop minimally invasive devices for cancer treatment.
Leonhardt Ventures | Howard Leonhardt, CEO
The company is focused on organ regeneration & recovery innovations based on the convergence of bioelectrics & biologics.
TibaRay | Jeff Amacker, CEO
TibaRay is developing a next-generation radiation therapy technology, called PHASER, to deliver radiation treatment with unprecedented accuracy and exquisite shaping by ultrafast imaging.